Global Insulin Glargine Competitive Landscape Professional Research Report 2024

Global Insulin Glargine Competitive Landscape Professional Research Report 2024



Research Summary

Insulin glargine is a long-acting insulin analog used to manage blood sugar levels in individuals with diabetes. It is designed to provide a steady and prolonged release of insulin, mimicking the basal insulin secretion pattern of the body. Insulin glargine works by lowering blood sugar levels by facilitating the uptake of glucose into cells and inhibiting the production of glucose in the liver. Unlike regular insulin, insulin glargine has a slower onset and a more consistent effect, helping to maintain stable blood sugar levels throughout the day and night. It is typically administered once daily, preferably at the same time each day, to provide continuous coverage and reduce the risk of hypoglycemia. Insulin glargine is available in various formulations, including Lantus, Basaglar, and Toujeo, and is commonly prescribed for individuals with type 1 and type 2 diabetes who require basal insulin therapy to manage their condition effectively.

According to DIResearch's in-depth investigation and research, the global Insulin Glargine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Insulin Glargine include Sanofi-Aventis, Ganlee, Biocon etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Insulin Glargine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Insulin Glargine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Insulin Glargine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Insulin Glargine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Insulin Glargine Include:

Sanofi-Aventis

Ganlee

Biocon

Insulin Glargine Product Segment Include:

Single Dose Vial

Pre-filled Syringe

Insulin Glargine Product Application Include:

Treat Type2 Diabetes

Treat Type1 Diabetes

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Insulin Glargine Industry PESTEL Analysis

Chapter 3: Global Insulin Glargine Industry Porter’s Five Forces Analysis

Chapter 4: Global Insulin Glargine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Insulin Glargine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Insulin Glargine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Insulin Glargine Market Overview
1.1 Product Definition and Statistical Scope
1.2 Insulin Glargine Product by Type
1.2.1 Global Insulin Glargine Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Insulin Glargine Product by Application
1.3.1 Global Insulin Glargine Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Global Insulin Glargine Market Revenue and Sales Analysis
1.4.1 Global Insulin Glargine Market Size Analysis (2019-2030)
1.4.2 Global Insulin Glargine Market Sales Analysis (2019-2030)
1.4.3 Global Insulin Glargine Market Sales Price Trend Analysis (2019-2030)
1.5 Insulin Glargine Market Development Status and Trends
1.5.1 Insulin Glargine Industry Development Status Analysis
1.5.2 Insulin Glargine Industry Development Trends Analysis
2 Insulin Glargine Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Insulin Glargine Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Insulin Glargine Market Analysis by Regions
4.1 Insulin Glargine Overall Market: 2023 VS 2024 VS 2030
4.2 Global Insulin Glargine Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Insulin Glargine Revenue and Market Share by Region (2019-2024)
4.2.2 Global Insulin Glargine Revenue Forecast by Region (2025-2030)
4.3 Global Insulin Glargine Sales and Forecast Analysis (2019-2030)
4.3.1 Global Insulin Glargine Sales and Market Share by Region (2019-2024)
4.3.2 Global Insulin Glargine Sales Forecast by Region (2025-2030)
4.4 Global Insulin Glargine Sales Price Trend Analysis (2019-2030)
5 Global Insulin Glargine Market Size by Type and Application
5.1 Global Insulin Glargine Market Size by Type
5.1.1 Global Insulin Glargine Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Insulin Glargine Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Insulin Glargine Market Size by Application
5.2.1 Global Insulin Glargine Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Insulin Glargine Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Insulin Glargine Market Size by Type
6.3.1 North America Insulin Glargine Sales by Type (2019-2030)
6.3.2 North America Insulin Glargine Revenue by Type (2019-2030)
6.4 North America Insulin Glargine Market Size by Application
6.4.1 North America Insulin Glargine Sales by Application (2019-2030)
6.4.2 North America Insulin Glargine Revenue by Application (2019-2030)
6.5 North America Insulin Glargine Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Insulin Glargine Market Size by Type
7.3.1 Europe Insulin Glargine Sales by Type (2019-2030)
7.3.2 Europe Insulin Glargine Revenue by Type (2019-2030)
7.4 Europe Insulin Glargine Market Size by Application
7.4.1 Europe Insulin Glargine Sales by Application (2019-2030)
7.4.2  Europe Insulin Glargine Revenue by Application (2019-2030)
7.5 Europe Insulin Glargine Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Insulin Glargine Market Size by Type
8.3.1 China Insulin Glargine Sales by Type (2019-2030)
8.3.2 China Insulin Glargine Revenue by Type (2019-2030)
8.4 China Insulin Glargine Market Size by Application
8.4.1 China Insulin Glargine Sales by Application (2019-2030)
8.4.2 China Insulin Glargine Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Insulin Glargine Market Size by Type
9.3.1 APAC (excl. China) Insulin Glargine Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Insulin Glargine Revenue by Type (2019-2030)
9.4 APAC (excl. China) Insulin Glargine Market Size by Application
9.4.1 APAC (excl. China) Insulin Glargine Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Insulin Glargine Revenue by Application (2019-2030)
9.5 APAC (excl. China) Insulin Glargine Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Insulin Glargine Market Size by Type
10.3.1 Latin America Insulin Glargine Sales by Type (2019-2030)
10.3.2 Latin America Insulin Glargine Revenue by Type (2019-2030)
10.4 Latin America Insulin Glargine Market Size by Application
10.4.1 Latin America Insulin Glargine Sales by Application (2019-2030)
10.4.2 Latin America Insulin Glargine Revenue by Application (2019-2030)
10.5 Latin America Insulin Glargine Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Insulin Glargine Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Insulin Glargine Market Size by Type
11.3.1 Middle East & Africa Insulin Glargine Sales by Type (2019-2030)
11.3.2 Middle East & Africa Insulin Glargine Revenue by Type (2019-2030)
11.4 Middle East & Africa Insulin Glargine Market Size by Application
11.4.1 Middle East & Africa Insulin Glargine Sales by Application (2019-2030)
11.4.2 Middle East & Africa Insulin Glargine Revenue by Application (2019-2030)
11.5 Middle East & Africa Insulin Glargine Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Insulin Glargine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Insulin Glargine Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Insulin Glargine Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Insulin Glargine Average Sales Price by Manufacturers (2020-2024)
12.2 Insulin Glargine Competitive Landscape Analysis and Market Dynamic
12.2.1 Insulin Glargine Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Sanofi-Aventis
13.1.1 Sanofi-Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Sanofi-Aventis Insulin Glargine Product Portfolio
13.1.3 Sanofi-Aventis Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 Ganlee
13.2.1 Ganlee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Ganlee Insulin Glargine Product Portfolio
13.2.3 Ganlee Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Biocon
13.3.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Biocon Insulin Glargine Product Portfolio
13.3.3 Biocon Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Insulin Glargine Industry Chain Analysis
14.2 Insulin Glargine Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Insulin Glargine Typical Downstream Customers
14.4 Insulin Glargine Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings